IP Library › Granted Patent US 11,406,106
Granted Patent B2
US 11,406,106 · App. 17/398,260 · Granted Aug 9, 2022

Alcohol-free hydrogen peroxide disinfectant compositions and methods of use thereof

Inventors: Carl F. Banas (West Springfield, MA); Christopher C. Valdes (West Springfield, MA); David Rinaldi (West Springfield, MA); Christopher A. Corridan (West Springfield, MA); Damon J. D'Amico (West Springfield, MA)
Assignee: ALDEN MEDICAL, LLC
A01N59/00A01N25/02A01N37/02A01N37/40A01P1/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,406,106
App. No.
17/398,260
Granted
Aug 9, 2022
Kind
B2
Abstract

Disclosed are low-level hydrogen peroxide aqueous-based disinfectant compositions that are substantially free of or do not contain volatile short chain (C1-C7) alcohols and exhibit broad spectrum antimicrobial/microbicidal activity against a variety of microorganisms including mycobacteria. Also disclosed are methods for using the compositions for the disinfection or sterilization of a variety hard surfaces such as those found in dental, hospital, and clinical environments or in food preparation environments.

Claims (34)

1. An aqueous-based disinfecting composition comprising:

(a) hydrogen peroxide at a concentration of 0.3 to 0.7% w/w,

(b) caprylic acid, or salt thereof at a concentration of 0.1 to 5% w/w,

(c) salicylic acid, or salt thereof at a concentration of 0.1 to 5% w/w,

(d) sodium C14-C16 olefin sulfonate at a concentration of 0.1 to 5% w/w, and

(e) water,

wherein the composition does not include or is substantially free of a volatile C1-C7 alcohol, and wherein the pH of the composition is from 1 to 2.

2. The composition of claim 1 , wherein the composition further comprises a sequestering or chelating agent.

3. The composition of claim 2 , wherein the sequestering or chelating agent is etidronic acid (HEDP) at a concentration of 0.1 to 5% w/w.

4. The composition of claim 1 , wherein the composition further comprises formic acid, or salt thereof at a concentration of 0.01 to 5% w/w.

5. The composition of claim 1 , wherein the composition further comprises sodium lauryl sulfate at a concentration of 0.1 to 5% w/w.

6. The composition of claim 1 , wherein, the concentration of caprylic acid, or salt thereof is 0.1 to 1.0% w/w, and wherein the concentration of salicylic acid, or salt thereof is 0.1 to 0.5% w/w.

7. The composition of claim 1 , wherein the composition further comprises a fragrance and/or a dye.

8. A method of disinfecting or sterilizing a surface, the method comprising: contacting the composition of claim 1 with the surface and allowing the composition to remain in contact with the surface for a period of time thereby disinfecting or sterilizing the surface.

9. The method of claim 8 , wherein the period of time is at least 1 minute.

10. The method of claim 8 , wherein the surface is at least a portion of the surface of medical equipment, medical devices, medical tools, or medical instruments.

11. An aqueous-based disinfecting composition comprising:

(a) hydrogen peroxide at a concentration of 0.1 to 0.9% w/w,

(b) one or more linear monocarboxylic acids with a carbon chain length of C5 to C12, or salt thereof, at a concentration of about 0.01 to about 5% w/w,

(c) salicylic acid at a concentration of about 0.01 to about 5% w/w,

(d) one or more sodium olefin sulfonate surfactants at a concentration of about 0.01 to about 5% w/w, and

(e) water,

wherein the composition does not contain or is substantially free of a volatile C1-C7 alcohol, and wherein the pH of the composition is from 0.1 to 2, and

wherein the one or more linear monocarboxylic acids with a carbon chain length of C5 to C12, or salt thereof is caprylic acid (C8), or salt thereof, and/or capric acid (C10), or salt thereof.

12. The composition of claim 11 , wherein the composition further comprises a sequestering or chelating agent.

13. The composition of claim 12 , wherein the sequestering or chelating agent is etidronic acid (HEDP), or salt thereof.

14. The composition of claim 11 , further comprising one or more linear monocarboxylic acids with a carbon chain length of C1 to C4, or salt thereof at a concentration of about 0.01 to about 5% w/w.

15. The composition of claim 14 , wherein the one or more linear monocarboxylic acids with a carbon chain length of C1 to C4, or salt thereof is formic acid.

16. The composition of claim 11 , further comprising one or more sodium C8 to C16 alkyl sulfate surfactants at a concentration of about 0.01 to about 5% w/w.

17. The composition of claim 16 , wherein the one or more sodium C8 to C16 alkyl sulfate surfactants is sodium lauryl sulfate.

18. The composition of claim 11 , wherein the sodium olefin sulfonate surfactant is sodium C14-C16 olefin sulfonate.

19. The composition of claim 11 , wherein the one or more linear monocarboxylic acids with a carbon chain length of C5 to C12, or salt thereof is caprylic acid (C8), or salt thereof at a concentration of 0.1 to 1.0% w/w; and wherein the salicylic acid, or salt thereof is at a concentration of 0.1 to 0.5% w/w.

20. The composition of claim 11 , wherein the composition further comprises a fragrance and/or dye.

21. The composition of claim 11 , wherein the composition is capable of exhibiting antimicrobial or bactericidal activity against microorganisms on a surface when the composition is in contact with the microorganisms for at least 1 minute, wherein the microorganisms are one or more of gram-positive bacteria, gram-negative bacteria, fungi, yeasts, molds, or mycobacteria.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 22, 2022
From: BANAS, CARL F.; VALDES, CHRISTOPHER C.; RINALDI, DAVID; CORRIDAN, CHRISTOPHER A.; D'AMICO, DAMON J.
To: ALDEN MEDICAL, LLC
Reel/Frame 060220/0890 →
Continuity (5)
Continuation PCTUS2020017909 · Feb 12, 2020
Provisional Application 62940013 · Nov 25, 2019
Provisional Application 62913946 · Oct 11, 2019
Provisional Application 62804588 · Feb 12, 2019
Related Publication 20210360927A1 · Nov 25, 2021